Next Generation Sequencing (NGS) Market Research Report and Forecast with Impact of COVID-19

Global Next-Generation Sequencing (NGS) Market Research Report and Forecast 2025

www.imarcgroup.com

Sales@imarcgroup.com

+1-631-791-1145

About IMARC

WHO WE ARE? • We are a leading market research firm with expertise in market intelligence and business research • We deliver high quality, well-knitted, meaningful studies • We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions

WHAT DO WE DO? • Market research and business insights • Competitive intelligence and benchmarking • Strategy consulting • Consumer surveys and feedback analysis

WHAT DO WE COVER? • Food And beverages • Dairy and dairy products • Agriculture and farming • Chemicals and materials • FMCG • Paper and packaging

• Social and rural research

• Healthcare

• Market entry strategy

• Machinery, electronics and semiconductors

• Syndicated Reports

WHO DO WE SERVE? • Collaborating with fortune 500 companies and SMEs • Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.

WhatWe Do

Competitive Intelligence and Benchmarking At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players.

Cost Modeling and Cost Forecasting A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions.

Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic

Country Entry Strategy IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more.

Consumer Survey & Feedback Reports Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services

Competitive Intelligence and Benchmarking

Market Research & Business Insights

Consumer Survey & Feedback Reports

Country Entry Strategy

Cost Modeling and Cost Forecasting

REPORT OBJECTIVES & Highlight

Report Description According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global next generation sequencing (NGS) market is expanding at double digit growth rate and is expected to grow at a CAGR of 17% during 2020-2025.

Next-generation sequencing refers to the process of determining the sequence of nucleotides in DNA. It involves various procedures, such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time (SMRT) sequencing. Next-generation sequencing is a cost-effective solution that offers faster and highly precise results. This enables the analysis of millions of DNA molecules, which facilitates research activities in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The growing prevalence of chronic diseases, such as cancer, along with several technological advancements in the field of medical sciences are primarily driving the next generation sequencing market. Furthermore, due to the widespread utilization of liquid biopsies in cancer diagnosis, there has been an increasing demand for NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Additionally, the increasing adoption of genome mapping solutions to forecast and analyze numerous chronic ailments is also propelling the market. Other factors, such as declining costs of NGS technologies and numerous R&D activities in the field of sequencing chemistry, are further expected to drive the next generation sequencing (NGS) market growth in the coming years.

Get a PDF sample of this research report: https://www.imarcgroup.com/next-generation-sequencing-market/requestsample

Report Description

Next Generation Sequencing Market 2020-2025 Competitive Analysis and Segmentation: Competitive Landscape: The competitive landscape of the next generation sequencing market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:  Agilent Technologies  Becton Dickinson and Company  10x Genomics  BGI Group  Eurofins Scientific  F. Hoffmann-La Roche AG  Illumina Inc.  Genewiz  Macrogen  Oxford Nanopore Technologies  Pacific Biosciences  PerkinElmer  Thermo Fisher Scientific  Qiagen N.V.  GenapSys Inc.

Report Description The report has segmented the global next generation sequencing market on the basis of sequencing type, product type, technology, application, end-user and region.

Breakup by Sequencing Type: 

Whole Genome Sequencing



Targeted Resequencing



Whole Exome Sequencing



RNA Sequencing



CHIP Sequencing



De Novo Sequencing



Methyl Sequencing



Others

Breakup by Product Type: 

Instruments



Reagents and Consumables



Software and Services

Report Description Breakup by Technology: 

Sequencing by Synthesis



Ion Semiconductor Sequencing



Single-Molecule Real-Time Sequencing



Nanopore Sequencing



Others

Breakup by Application: 

Drug Discovery and Personalized Medicine



Genetic Screening



Diagnostics



Agriculture and Animal Research



Others

Breakup by End-User: 

Academic Institutes & Research Centers



Hospitals & Clinics



Pharmaceutical & Biotechnology Companies



Others

Report Description Breakup by Region: 









North America o United States o Canada Asia Pacific o China o Japan o India o South Korea o Australia o Indonesia o Others Europe o Germany o France o United Kingdom o Italy o Spain o Russia o Others Latin America o Brazil o Mexico o Others Middle East and Africa

Report Description Explore full report with table of contents: https://www.imarcgroup.com/next-generation-sequencing-market Key highlights of the report:  Market Performance (2014-2019) 

Market Outlook (2020- 2025)



Market Drivers and Success Factors



Industry Trends



The Impact of COVID-19 on the Market



Value Chain Analysis



Structure of the Global Market



Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Report: https://www.imarcgroup.com/laparoscopic-devices-market https://www.imarcgroup.com/spinal-implants-surgery-devices-market

Report Description About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide.

We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com Email: sales@imarcgroup.com USA: +1-631-791-1145 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group

Table of Contents

Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Next-Generation Sequencing Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Sequencing Type 6.1 Whole Genome Sequencing 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Targeted Resequencing 6.2.1 Market Trends 6.2.2 Market Forecast

Table of Contents 6.3 Whole Exome Sequencing 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 RNA Sequencing 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 CHIP Sequencing 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 De Novo Sequencing 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Methyl Sequencing 6.7.1 Market Trends 6.7.2 Market Forecast 6.8 Others 6.8.1 Market Trends 6.8.2 Market Forecast 7 Market Breakup by Product Type 7.1 Instruments 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Reagents and Consumables 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Software and Services 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Technology

Table of Contents 8.1 Sequencing by Synthesis 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ion Semiconductor Sequencing 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Single-Molecule Real-Time Sequencing 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Nanopore Sequencing 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by Application 9.1 Drug Discovery and Personalized Medicine 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Genetic Screening 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Diagnostics 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Agriculture and Animal Research 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others

Table of Contents 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by End-User 10.1 Academic Institutes & Research Centers 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Hospitals & Clinics 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Pharmaceutical & Biotechnology Companies 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Others 10.4.1 Market Trends 10.4.2 Market Forecast 11 Market Breakup by Region 11.1 North America 11.1.1 United States 11.1.1.1 Market Trends 11.1.1.2 Market Forecast 11.1.2 Canada 11.1.2.1 Market Trends 11.1.2.2 Market Forecast 11.2 Asia Pacific 11.2.1 China 11.2.1.1 Market Trends 11.2.1.2 Market Forecast 11.2.2 Japan 11.2.2.1 Market Trends

Table of Contents 11.2.2.2 Market Forecast 11.2.3 India 11.2.3.1 Market Trends 11.2.3.2 Market Forecast 11.2.4 South Korea 11.2.4.1 Market Trends 11.2.4.2 Market Forecast 11.2.5 Australia 11.2.5.1 Market Trends 11.2.5.2 Market Forecast 11.2.6 Indonesia 11.2.6.1 Market Trends 11.2.6.2 Market Forecast 11.2.7 Others 11.2.7.1 Market Trends 11.2.7.2 Market Forecast 11.3 Europe 11.3.1 Germany 11.3.1.1 Market Trends 11.3.1.2 Market Forecast 11.3.2 France 11.3.2.1 Market Trends 11.3.2.2 Market Forecast 11.3.3 United Kingdom 11.3.3.1 Market Trends 11.3.3.2 Market Forecast 11.3.4 Italy 11.3.4.1 Market Trends 11.3.4.2 Market Forecast

Table of Contents 11.3.5 Spain 11.3.5.1 Market Trends 11.3.5.2 Market Forecast 11.3.6 Russia 11.3.6.1 Market Trends 11.3.6.2 Market Forecast 11.3.7 Others 11.3.7.1 Market Trends 11.3.7.2 Market Forecast 11.4 Latin America 11.4.1 Brazil 11.4.1.1 Market Trends 11.4.1.2 Market Forecast 11.4.2 Mexico 11.4.2.1 Market Trends 11.4.2.2 Market Forecast 11.4.3 Others 11.4.3.1 Market Trends 11.4.3.2 Market Forecast 11.5 Middle East and Africa 11.5.1 Market Trends 11.5.2 Market Breakup by Country 11.5.3 Market Forecast 12 SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats

Table of Contents 13 Value Chain Analysis 14 Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes 15 Price Indicators 16 Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 Agilent Technologies Inc. 16.3.1.1 Company Overview 16.3.1.2 Product Portfolio 16.3.1.3 Financials 16.3.1.4 SWOT Analysis 16.3.2 Becton Dickinson and Company 16.3.2.1 Company Overview 16.3.2.2 Product Portfolio 16.3.2.3 Financials 16.3.2.4 SWOT Analysis 16.3.3 10x Genomics 16.3.3.1 Company Overview 16.3.3.2 Product Portfolio 16.3.4 BGI Group 16.3.4.1 Company Overview 16.3.4.2 Product Portfolio

Table of Contents 16.3.5 Eurofins Scientific 16.3.5.1 Company Overview 16.3.5.2 Product Portfolio 16.3.6 F. Hoffmann-La Roche AG 16.3.6.1 Company Overview 16.3.6.2 Product Portfolio 16.3.6.3 Financials 16.3.7 Illumina Inc. 16.3.7.1 Company Overview 16.3.7.2 Product Portfolio 16.3.7.3 Financials 16.3.7.4 SWOT Analysis 16.3.8 Genewiz 16.3.8.1 Company Overview 16.3.8.2 Product Portfolio 16.3.9 Macrogen Inc. 16.3.9.1 Company Overview 16.3.9.2 Product Portfolio 16.3.9.3 Financials 16.3.10 Oxford Nanopore Technologies 16.3.10.1 Company Overview 16.3.10.2 Product Portfolio 16.3.10.3 Financials 16.3.10.4 SWOT Analysis 16.3.11 Pacific Biosciences 16.3.11.1 Company Overview 16.3.11.2 Product Portfolio 16.3.11.3 Financials 16.3.12 Perkinelmer Inc.

Table of Contents 16.3.12.1 Company Overview 16.3.12.2 Product Portfolio 16.3.12.3 Financials 16.3.12.4 SWOT Analysis 16.3.13 Thermo Fisher Scientific Inc. 16.3.13.1 Company Overview 16.3.13.2 Product Portfolio 16.3.13.3 Financials 16.3.13.4 SWOT Analysis 16.3.14 Qiagen N.V. 16.3.14.1 Company Overview 16.3.14.2 Product Portfolio 16.3.14.3 Financials 16.3.14.4 SWOT Analysis 16.3.15 Genapsys Inc. 16.3.15.1 Company Overview 16.3.15.2 Product Portfolio

Report FAQs Team Team Profile Profile

Team Profile

Engineers and Post Graduates Account for 75% of our Team

Growing team of 150+ employees with deep market knowledge

Over 1000 Independent Consultants from different sectors

Post Graduates; 30.00%

Engineers; 45.00%

Non Engineering Graduates; 15.00% Others; 10.00%

Talents from some of the top universities

modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Commercial and non-commercial relationships with some of the top research institutes

Report FAQs Words From Client

Words From Client

“We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.”

-Global Procurement Technology Manager – Global FMCG Giant “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.”

-Vice President Marketing – European Diagnostic Company

“We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.”

-National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company

Report FAQs

Report FAQs

Report FAQs

01 02 03 04 05

Do you provide market share information for a specific country/segment?

Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements.

My research requirement is very specific; can I customized the report?

Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations.

How do you arrive at the market numbers?

Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis.

The third step is data validation from industry experts, key players and other stakeholders.

I have a pre-defined budget. Can I buy chapters/sections of the report?

We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement.

Do you offer post sales support?

Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.

Report FAQs

06 07 08 09

Who are your client?

We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services

How will I receive the report?

The report in a PDF and Excel format will be sent to you electronically at your registered email address.

Moreover, PPT and Word formats are also delivered to clients, on special requests.

How often does IMARC update studies?

Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status.

Will I have to pay for the post-sale customization needs?

We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.

SOME OF OUR KEY CUSTOMERS